Literature DB >> 1934217

Anaesthesia and the child with HIV infection.

D Schwartz1, T Schwartz, E Cooper, J Pullerits.   

Abstract

The frequency of AIDS in the paediatric population is growing rapidly and is expected to get worse. The anaesthetist will participate in the care of these children in the operating room and the intensive care unit with increasing frequency and must therefore have an understanding of the many manifestations of this syndrome. Children become infected with HIV by transplacental transmission from mother to fetus in over 80% of cases. Early diagnosis in infants can be very difficult. Clinical manifestations of HIV infection in children result from damage to almost every organ system. Considerations for the anaesthetist include: the effects of medications, cardiovascular dysfunction, pulmonary disease, altered metabolism, equipment preparation, choice of anaesthetic, modes of viral transmission and psycho-social issues.

Entities:  

Mesh:

Year:  1991        PMID: 1934217     DOI: 10.1007/BF03008200

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  33 in total

1.  Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments.

Authors:  L Resnick; K Veren; S Z Salahuddin; S Tondreau; P D Markham
Journal:  JAMA       Date:  1986-04-11       Impact factor: 56.272

2.  Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1987-04-24       Impact factor: 17.586

Review 3.  Acquired immunodeficiency syndrome: a new population of children at risk.

Authors:  E R Cooper; S I Pelton; M LeMay
Journal:  Pediatr Clin North Am       Date:  1988-12       Impact factor: 3.278

4.  Congenital cardiac toxoplasmosis in a newborn with acquired immunodeficiency syndrome.

Authors:  M D Medlock; J T Tilleli; G S Pearl
Journal:  Pediatr Infect Dis J       Date:  1990-02       Impact factor: 2.129

5.  Outcome after assisted ventilation in children with acquired immunodeficiency syndrome.

Authors:  D A Notterman; B M Greenwald; A Di Maio-Hunter; J D Wilkinson; K Krasinski; W Borkowsky
Journal:  Crit Care Med       Date:  1990-01       Impact factor: 7.598

Review 6.  Human T-cell lymphotropic virus type III (HTLV-III) infection: how it can affect you, your patients, and your anesthesia practice.

Authors:  S E Kunkel; M A Warner
Journal:  Anesthesiology       Date:  1987-02       Impact factor: 7.892

7.  Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus.

Authors:  R Marcus
Journal:  N Engl J Med       Date:  1988-10-27       Impact factor: 91.245

8.  Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.

Authors:  J S McDougal; L S Martin; S P Cort; M Mozen; C M Heldebrant; B L Evatt
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

9.  Infection of the heart by the human immunodeficiency virus.

Authors:  W W Grody; L Cheng; W Lewis
Journal:  Am J Cardiol       Date:  1990-07-15       Impact factor: 2.778

10.  AIDS and anaesthesia.

Authors:  K G Lee; N Soni
Journal:  Anaesthesia       Date:  1986-10       Impact factor: 6.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.